Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis
Bioscience, Biotechnology, and Biochemistry · 2025
DOI: 10.1093/bbb/zbaf091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2025. Verfasst von Yuta Tsunematsu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Aichi, Japan. Hauptthemen laut MEDLINE: Cyclohexanes, Sesquiterpenes, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Fumagillin-class natural products, known as methionine aminopeptidase 2 inhibitors, have been explored as drug candidates for cancer, obesity, and infectious diseases such as amoebiasis. However, clinical development has been hindered by adverse effects. Here, we identified 2 fumagillin analogues via engineered biosynthesis in Saccharomyces cerevisiae, coupled with metabolomics and activity-guided isolation. Spectroscopic analysis revealed unique 6-oxabicyclo[3.2.1]octane scaffolds that are unprecedented among naturally occurring fumagillins. The compounds exhibited selective antiamoebic activity without cytotoxicity to human lung cells. Stereochemical and computational studies suggested that the unique bicyclic system arises from a twist-boat conformer that enables intramolecular ether formation. These findings demonstrate that biosynthetic pathway engineering can expand the chemical diversity of fumagillin-related molecules and provide new leads for antiparasitic drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Aichi, Japan.
- School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
- Science and Innovation Center, Mitsubishi Chemical Corporation, Kanagawa, Japan.
- Department of Parasitology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
- Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Yuta Tsunematsu, Kouichi Yoshinari, Kenji Watanabe
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Tsunematsu, Y., Ogata, Y., Niwa, K., Ogata, N., Kobayashi, S., Sato, M., Matsushita, T., Shizu, R., Yoshinari, K., Mori, M., Saito-Nakano, Y., Nozaki, T., & Watanabe, K. (2025). Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbaf091
Vancouver
Tsunematsu Y, Ogata Y, Niwa K, Ogata N, Kobayashi S, Sato M, et al. Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis. Bioscience, Biotechnology, and Biochemistry. 2025. doi:10.1093/bbb/zbaf091
BibTeX
@article{Tsunematsu2025,
author = {Tsunematsu, Yuta and Ogata, Yuji and Niwa, Kanji and Ogata, Namiko and Kobayashi, Seiki and Sato, Michio and Matsushita, Takuma and Shizu, Ryota and Yoshinari, Kouichi and Mori, Mihoko and Saito-Nakano, Yumiko and Nozaki, Tomoyoshi and Watanabe, Kenji},
title = {Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2025},
doi = {10.1093/bbb/zbaf091}
}
EUVIMED